Expression profiles of the nuclear receptors and their transcriptional coregulators during differentiation of neural stem cells

Hormone and Metabolic Research

Volumn 45, Issue 2, 2013, Pages 159-168

  Androutsellis Theotokis, A ^a   Chrousos, G P ^b   McKay, R D ^c   Decherney, A H ^d   Kino, T ^d  

^a CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

central nervous system; glucocorticoid; histone deacetylase; mineralocorticoid; neuron

Indexed keywords

ALDOSTERONE; CELL NUCLEUS RECEPTOR; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 2; HISTONE DEACETYLASE; MESSENGER RNA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RETINOID X RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL COUNT; CENTRAL NERVOUS SYSTEM; EMBRYO; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; XENOBIOTIC METABOLISM;

ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; EMBRYO, MAMMALIAN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCOCORTICOIDS; HISTONE DEACETYLASE INHIBITORS; IMMUNOHISTOCHEMISTRY; MICE; MINERALOCORTICOIDS; NEURAL STEM CELLS; NEURONS; NUCLEAR PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84874107948     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1321789     Document Type: Article

References (45)

1. Burris TP. The nuclear receptor superfamily. In: Burris T. P., McCabe ER B. (eds.) Nuclear receptors and genetic disease. London Academic Press: 2001; 1 58
2. Horn S., Heuer H. Thyroid hormone action during brain development: More questions than answers. Mol Cell Endocrinol: 2010; 315 19 26
3. Wolkowitz O. M., Burke H., Epel E. S., Reus V. I. Glucocorticoids. Mood, memory, and mechanisms. Ann N Y Acad Sci: 2009; 1179 19 40
4. Hughes Z. A., Liu F., Marquis K., Muniz L., Pangalos M. N., Ring R. H., Whiteside G. T., Brandon N. J. Estrogen receptor neurobiology and its potential for translation into broad spectrum therapeutics for CNS disorders. Curr Mol Pharmacol: 2009; 2 215 236
5. Kino T., Chrousos G. P. Glucocorticoid effect on gene expression. In: Steckler T., Kalin N. H., Reul JMH M. eds. Handbook on Stress and the Brain. Amsterdam Elsevier BV: 2005; 295 312
6. McKenna N. J., Lanz R. B., O'Malley B. W. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev: 1999; 20 321 344
7. Kino T., Hurt D. E., Ichijo T., Nader N., Chrousos G. P. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal: 2010; 3 ra8
8. Androutsellis-Theotokis A., Murase S., Boyd J. D., Park D. M., Hoeppner D. J., Ravin R., McKay R. D. Generating neurons from stem cells. Methods Mol Biol: 2008; 438 31 38
9. Androutsellis-Theotokis A., Rueger M. A., Park D. M., Mkhikian H., Korb E., Poser S. W., Walbridge S., Munasinghe J., Koretsky A. P., Lonser R. R., McKay R. D. Targeting neural precursors in the adult brain rescues injured dopamine neurons. Proc Natl Acad Sci USA: 2009; 106 13570 13575
10. Androutsellis-Theotokis A., Rubin de Celis M. F., Ehrhart-Bornstein M., Bornstein S. R. Common features between chromaffin and neural progenitor cells. Mol Psychiatry: 2012; 17 351
11. Bornstein S. R., Ehrhart-Bornstein M., Androutsellis-Theotokis A., Eisenhofer G., Vukicevic V., Licinio J., Wong M. L., Calissano P., Nistico G., Preziosi P., Levi-Montalcini R. Chromaffin cells: the peripheral brain. Mol Psychiatry: 2012; 17 354 358
12. Androutsellis-Theotokis A., Leker R. R., Soldner F., Hoeppner D. J., Ravin R., Poser S. W., Rueger M. A., Bae S. K., Kittappa R., McKay R. D. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature: 2006; 442 823 826
13. Androutsellis-Theotokis A., Rueger M. A., Mkhikian H., Korb E., McKay R. D. Signaling pathways controlling neural stem cells slow progressive brain disease. Cold Spring Harb Symp Quant Biol: 2008; 73 403 410
14. Kittappa R., Bornstein S. R., Androutsellis-Theotokis A. The role of eNSCs in neurodegenerative disease. Mol Neurobiol: 2012; in press
15. Ng S. S., Chang T. H., Tailor P., Ozato K., Kino T. Virus-induced differential expression of nuclear receptors and coregulators in dendritic cells: Implication to interferon production. FEBS Lett: 2011; 585 1331 1337
16. Kino T., Ichijo T., Amin N. D., Kesavapany S., Wang Y., Kim N., Rao S., Player A., Zheng Y. L., Garabedian M. J., Kawasaki E., Pant H. C., Chrousos G. P. Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: Clinical Implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol: 2007; 21 1552 1568
17. van Neerven S., Kampmann E., Mey J. RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases. Prog Neurobiol: 2008; 85 433 451
18. Pereira F. A., Qiu Y., Tsai M. J., Tsai S. Y. Chicken ovalbumin upstream promoter transcription factor (COUP-TF) expression during mouse embryogenesis. J Steroid Biochem Mol Biol: 1995; 53 503 508
19. Levesque D., Rouillard C. Nur77 and retinoid X receptors: Crucial factors in dopamine-related neuroadaptation. Trends Neurosci: 2007; 30 22 30
20. Hall M. G., Quignodon L., Desvergne B. Peroxisome proliferator-activated receptor β/δ in the brain: Facts and hypothesis. PPAR Res 2008; 2008: 780452
21. Lee Y. F., Lee H. J., Chang C. Recent advances in the TR2 and TR4 orphan receptors of the nuclear receptor superfamily. J Steroid Biochem Mol Biol: 2002; 81 291 308
22. Schnegg C. I., Robbins M. E. Neuroprotective mechanisms of PPARδ: Modulation of oxidative stress and inflammatory processes. PPAR Res: 2011; 2011 373560
23. Real M. A., Heredia R., Davila J. C., Guirado S. Efferent retinal projections visualized by immunohistochemical detection of the estrogen-related receptor β in the postnatal and adult mouse brain. Neurosci Lett: 2008; 438 48 53
24. Grgurevic N., Tobet S., Majdic G. Widespread expression of liver receptor homolog 1 in mouse brain. Neuro Endocrinol Lett: 2005; 26 541 547
25. Seckl J. R., Walker BR. Minireview: 11β-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology: 2001; 142 1371 1376
26. Almad A., McTigue D. M. Chronic expression of PPAR-δ by oligodendrocyte lineage cells in the injured rat spinal cord. J Comp Neurol: 2010; 518 785 799
27. D'Angelo B., Benedetti E., Di Loreto S., Cristiano L., Laurenti G., Ceru M. P., Cimini A. Signal transduction pathways involved in PPARβ/δ- induced neuronal differentiation. J Cell Physiol: 2011; 226 2170 2180
28. Schnegg C. I., Kooshki M., Hsu F. C., Sui G., Robbins M. E. PPARδ prevents radiation-induced proinflammatory responses in microglia via transrepression of NF-κB and inhibition of the PKCα/MEK1/2/ERK1/2/ AP-1 pathway. Free Radic Biol Med: 2012; 52 1734 1743
29. Siegel D. A., Davies P., Dobrenis K., Huang M. Tomoregulin-2 is found extensively in plaques in Alzheimer's disease brain. J Neurochem: 2006; 98 34 44
30. Zhou X. E., Suino-Powell K. M., Xu Y., Chan C. W., Tanabe O., Kruse S. W., Reynolds R., Engel J. D., Xu H. E. The orphan nuclear receptor TR4 is a vitamin A-activated nuclear receptor. J Biol Chem: 2011; 286 2877 2885
31. Sousa N., Almeida O. F. Corticosteroids: Sculptors of the hippocampal formation. Rev Neurosci: 2002; 13 59 84
32. Kino T., Chrousos G. P. Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. J Endocrinol: 2001; 169 437 445
33. th ed. New York McGraw-Hill: 2001; 609 632
34. Aimone J. B., Wiles J., Gage F. H. Potential role for adult neurogenesis in the encoding of time in new memories. Nat Neurosci: 2006; 9 723 727
35. Kukolja J., Thiel C. M., Wolf O. T., Fink G. R. Increased cortisol levels in cognitively challenging situations are beneficial in young but not older subjects. Psychopharmacology (Berl): 2008; 201 293 304
36. Gass P., Kretz O., Wolfer D. P., Berger S., Tronche F., Reichardt H. M., Kellendonk C., Lipp H. P., Schmid W., Schutz G. Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice. EMBO Rep: 2000; 1 447 451
37. Yu S., Yang S., Holsboer F., Sousa N., Almeida O. F. Glucocorticoid regulation of astrocytic fate and function. PLoS One: 2011; 6 e22419
38. Yu S., Patchev A. V., Wu Y., Lu J., Holsboer F., Zhang J. Z., Sousa N., Almeida O. F. Depletion of the neural precursor cell pool by glucocorticoids. Ann Neurol: 2010; 67 21 30
39. Kazantsev A. G., Thompson L. M. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov: 2008; 7 854 868
40. Sun G., Yu R. T., Evans R. M., Shi Y. Orphan nuclear receptor TLX recruits histone deacetylases to repress transcription and regulate neural stem cell proliferation. Proc Natl Acad Sci USA: 2007; 104 15282 15287
41. Sun G., Fu C., Shen C., Shi Y. Histone deacetylases in neural stem cells and induced pluripotent stem cells. J Biomed Biotechnol: 2011; 2011 835968
42. Chateauvieux S., Morceau F., Dicato M., Diederich M. Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol: 2010; 2010 479364
43. Faraco G., Cavone L., Chiarugi A. The therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosis. Mol Med: 2011; 17 442 447
44. Fischer A., Sananbenesi F., Mungenast A., Tsai L. H. Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol Sci: 2010; 31 605 617
45. Shein N. A., Shohami E. Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries. Mol Med: 2011; 17 448 456